Biocon Limited
BIOCON
Rang in aandelen
#3396
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Aandeelprijs
$3.75
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$5.13B
Verandering (1 dag)
-2.30%
Verandering (1 jaar)
-9.49%
Land
IN
Handel Biocon Limited (BIOCON)
Categorie
Healthcare
P/B-ratio voor Biocon Limited (BIOCON)
P/B-ratio op October 2026 TTM: 1.63
Volgens de meest recente financiële rapporten en aandelenkoers van Biocon Limited is de huidige P/B-ratio (TTM) 1.63. Eind 2024 had het bedrijf een P/B-ratio van 1.63.
P/B-ratiohistoriek voor Biocon Limited van 2004 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 1.63 | -13.16% |
| 2025 | 1.88 | 15.10% |
| 2024 | 1.63 | 18.32% |
| 2023 | 1.38 | -70.93% |
| 2022 | 4.74 | -25.52% |
| 2021 | 6.36 | 33.22% |
| 2020 | 4.78 | -20.52% |
| 2019 | 6.01 | -11.80% |
| 2018 | 6.82 | 48.33% |
| 2017 | 4.59 | 96.38% |
| 2016 | 2.34 | -18.48% |
| 2015 | 2.87 | 4.31% |
| 2014 | 2.75 | 31.60% |
| 2013 | 2.09 | 1.48% |
| 2012 | 2.06 | -37.93% |
| 2011 | 3.32 | 5.47% |
| 2010 | 3.15 | 72.13% |
| 2009 | 1.83 | -34.73% |
| 2008 | 2.80 | -36.29% |
| 2007 | 4.40 | -8.26% |
| 2006 | 4.79 | -7.95% |
| 2005 | 5.21 | -28.50% |
| 2004 | 7.28 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 6.251 | 282.91% |
US
|
|
| 13.2547 | 711.93% |
US
|
|
| 4.208 | 157.76% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 278.71% |
NL
|
